News
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has launched the AAW Automated ...
The two companies will scale production for a novel recombinant version of alpha-1 antitrypsin targeting lung diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback